Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis.

• Status: Not yet recruiting
• Trial end date: 2025-06-01

Summary

Primary objective:

To compare the bone mineral density (BMD) change under the treatment of denosumab with eldecalcitol or native vitamin D in postmenopausal women with osteoporosis on bone mineral density.

Secondary objective:

To compare the efficacy of denosumab with eldecalcitol or native vitamin D treatment in postmenopausal women with osteoporosis on bone turnover markers, serum PTH, serum calcium, serum phosphorus, muscle mass, muscle strength, body balance ability, and quality of life.

• Phase: Phase 4

Details

• Lead Sponsor: Xi'an Honghui Hospital
• Collaborator: Chugai Pharma China Co., Ltd.
• Treatments: Calcium; Denosumab; Eldecalcitol; Vitamin D